GRSRX
Price
$52.73
Change
-$0.22 (-0.42%)
Updated
May 22 closing price
Net Assets
1.94B
SREZX
Price
$13.02
Change
-$0.03 (-0.23%)
Updated
May 22 closing price
Net Assets
180.5M
Interact to see
Advertisement

GRSRX vs SREZX

Header iconGRSRX vs SREZX Comparison
Open Charts GRSRX vs SREZXBanner chart's image
Cohen & Steers Global Realty R
Price$52.73
Change-$0.22 (-0.42%)
VolumeN/A
Net Assets1.94B
PGIM Select Real Estate Z
Price$13.02
Change-$0.03 (-0.23%)
VolumeN/A
Net Assets180.5M
GRSRX vs SREZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRSRX vs. SREZX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRSRX is a Hold and SREZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GRSRX has more cash in the bank: 1.94B vs. SREZX (180M). SREZX pays higher dividends than GRSRX: SREZX (2.48) vs GRSRX (2.24). GRSRX was incepted earlier than SREZX: GRSRX (11 years) vs SREZX (11 years). GRSRX (1.34) is less costly to investors than SREZX (1.10). SREZX is a more actively managed with annual turnover of: 142.00 vs. GRSRX (67.00). GRSRX (0) and SREZX (0) have matching initial minimum investment requirements. SREZX annual gain was more profitable for investors over the last year : 8.00 vs. GRSRX (5.79). GRSRX (35.67) and SREZX (35.59) have equivalent 5 years return.
GRSRXSREZXGRSRX / SREZX
Total Expense Ratio1.341.06126%
Annual Report Gross Expense Ratio1.341.10122%
Fund Existence11 years11 years-
Gain YTD3.0691.023300%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B180M1,079%
Annual Yield % from dividends2.242.4890%
Returns for 1 year5.798.0072%
Returns for 3 years0.726.7411%
Returns for 5 years35.6735.59100%
Returns for 10 years30.5851.3260%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOXA55.14N/A
N/A
Fox Corp
PPBT2.37N/A
N/A
Purple Biotech Ltd
PTGX45.82N/A
N/A
Protagonist Therapeutics
LASR13.45N/A
N/A
nLIGHT
XTNT0.69N/A
N/A
Xtant Medical Holdings